Alefacept and Abatacept: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 16, 2026 · Source data updated Jul 16, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Abatacept
Alefacept
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both of these medicines quiet down your immune system. Abatacept (Orencia) and alefacept each work on immune cells to calm the inflammation behind conditions like rheumatoid arthritis or psoriasis. The concern is that using two immune-suppressing biologics together can dampen your defenses too much, which raises your risk of getting a serious infection, without giving you extra benefit.
The good news is that this is easy to manage. Because combining these types of drugs is generally not recommended, your care team will usually pick one biologic at a time. Please don't stop or change anything on your own, just talk with your doctor or pharmacist so they can guide the safest plan for you.
Effect: Additive immunosuppression increasing risk of serious infection, with no added therapeutic benefit. Neither agent is a prodrug; this is a pharmacodynamic (not metabolic) interaction.
- Direction: Both are immunomodulatory biologics; concurrent use compounds immune suppression.
- Mechanism: Unknown/additive PD; extrapolated from abatacept plus TNF antagonist trial data.
- Evidence: Theoretical for this specific pair; safety of abatacept with other RA/psoriatic biologics is uninvestigated.
- Onset: Unspecified.
- Management: Concurrent use not recommended. If transitioning from one biologic to abatacept, monitor for signs/symptoms of infection.
What happens
An increased risk of infection
Interaction Deep Dive
In controlled clinical studies, taking abatacept together with tumor necrosis factor (TNF) antagonists was shown to raise the likelihood of serious infection while offering no extra therapeutic advantage. Data are inadequate to judge the safety and effectiveness of abatacept combined with anakinra or with biologic agents used for rheumatoid arthritis or psoriatic arthritis. For this reason, using these medications alongside abatacept is not advised. Patients switching from TNF antagonist treatment to abatacept should be watched for indications of infection1.
Why it happens (mechanism)
Unknown
How to manage this interaction
What your care team typically does:
- Combining abatacept with another immune-suppressing biologic like alefacept is generally not recommended, so your team will usually choose one agent rather than using both together.
- If you are switching from one biologic to abatacept, your team will monitor you more closely for signs of infection (fever, chills, sore throat, cough, or wounds that won't heal).
What you can do: Keep taking your medicines as prescribed, don't start or stop anything on your own, and tell your pharmacist or prescriber about every biologic you take so they can tailor the safest plan and watch for infection.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
2 reports — tap to read
a) The combined use of abatacept and etanercept provided no additional efficacy while raising the risk of serious infection when compared with etanercept used alone. In a 1-year randomized study (N=121) that was followed by an open-label long-term extension (LTE; n=80), patients with rheumatoid arthritis who were already receiving etanercept 25 mg twice/week continued that etanercept and were randomized to receive either abatacept 2 mg/kg IV on days 1, 15, and 30, and then every 4 weeks (n=85) or placebo (n=36). After finishing the double-blind phase, patients qualified for the LTE phase, at which point the abatacept dose was raised to roughly 10 mg/kg. At 6 months, the 2 mg/kg abatacept group demonstrated no significant improvement relative to the placebo group in modified American College of Rheumatology 20% (ACR20; 48.2% vs 30.6%) or ACR50 (25.9% vs 19.4%) response rates, though there was a significant difference in modified ACR70 rates (10.6% vs 0%). At 1 year, no significant differences in ACR20, 50, or 70 response rates were seen between the two groups. Serious adverse events occurred more often in the 2 mg/kg abatacept group (16.5%) at one year and in the 10 mg/kg abatacept group after 2 years of LTE (32.5%) than in the placebo group (2.8%). Serious infections at 1 year were reported in 3.5% of the 2 mg/kg abatacept group and 0% of the placebo group 2.
b) In controlled clinical trials involving adults with active rheumatoid arthritis who received abatacept together with a tumor necrosis factor (TNF) antagonist (n=204), compared with those on TNF antagonist therapy alone (n=134), the rate of infection (63% vs 43%, respectively) and of serious infection (4.4% vs 0.8%, respectively) was higher with the combined therapy; furthermore, the combined therapy offered no additional benefit 1.
Common questions
Can I take Alefacept and Abatacept together?
Using abatacept and alefacept together can raise your infection risk without added benefit, so this combination is generally not recommended. Talk with your doctor or pharmacist, who will usually use one biologic at a time and watch closely for infection. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Alefacept and Abatacept interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Alefacept and Abatacept interaction managed?
What your care team typically does: Combining abatacept with another immune-suppressing biologic like alefacept is generally not recommended, so your team will usually choose one agent rather than using both together. If you are switching from one biologic to abatacept, your team will monitor you more closely for signs of infection (fever, chills, sore throat, cough, or wounds that won't heal). Wh… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Alefacept or Abatacept need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (2)
- Product Information: ORENCIA(R) intravenous, subcutaneous injection, abatacept intravenous, subcutaneous injection. Bristol-Myers Squibb Company (per FDA), Princeton, NJ, 2020. DailyMed
- Weinblatt M, Schiff M, Goldman A, et al: Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial. Ann Rheum Dis 2007; 66(2):228-234. PubMed
Keep reading about Abatacept
Keep reading about Alefacept
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist